癌症治疗中的拜卡林和拜卡林:多方面的机制,临床前证据和翻译挑战
Xavier Capó1, Rajesh Kumar2, Abhay Prakash Mishra3
1Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands-IUNICS, Mallorca, Spain; Translational Research in Aging and Longevity (TRIAL) Group, Health Research Institute of the Balearic Islands (IdISBa), Mallorca, Spain.
Seminars in oncology
|July 4, 2025
概括
来自Scutellaria baicalensis的天然黄素Baicalein和baicalin通过向关键癌症特征,显示出广泛的抗癌作用. 尽管存在药理动力学方面的挑战,但它们为整合性瘤学提供了一种有希望的低毒性方法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 自然化合物提供补充性癌症疗法.
- 来自Scutellaria baicalensis的黄素baicalein和baicalin具有抗癌性质.
- 传统的癌症治疗有其局限性.
研究的目的:
- 审查 Baicalein 和 baicalin 在瘤学中的药理潜力和翻译相关性.
- 综合来自临床前和早期临床研究的当前证据.
- 探索它们对抗癌症特征的作用机制.
主要方法:
- 关于细胞系统,动物模型和早期临床研究的文献综述.
- 对向癌症特征的分子机制的分析.
- 对药物动力学特性和配方策略的评估.
主要成果:
- 拜卡林和拜卡林抑制了癌症的扩散,生存,血管新生,转移和免疫规避.
- 它们调节细胞亡,炎症和细胞循环控制.
- 在体内研究显示瘤生长抑制;临床数据表明有利的安全性.
结论:
- 拜卡林和拜卡林是整合性瘤学的有前途的植物化学物质,因为它们具有类效应和低毒性.
- 药物动力学限制 (溶解性,生物可用性) 阻碍了临床转化.
- 对于先进的天然化合物疗法,需要进一步研究配方和目标定义.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K


